Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Effects of Lasmiditan in Healthy Elderly Subjects
NCT03406260Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2018
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lasmiditan in migraine (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Change From Baseline in Peak Hourly Mean Values of Systolic Blood Pressure. Started Jan 2018; status: completed.
02
Drugs
lasmiditan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03406260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03406260.